文献速递肺外科

所有肺叶切除术应常规清扫隆突下淋巴结:基于全国登记研究

Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
PubMed 文献 · Ann Thorac Surg · 2017-01-18

该研究利用全国肺癌登记数据,分析5577例接受肺叶切除术的非小细胞肺癌患者,发现最终病理证实的隐匿性N2转移占11.0%,其中隆突下转移占3.5%。中下叶肿瘤的隆突下N2发生率显著高于上叶(5.8% vs 1.6%,p<0.01),即使术前有创分期也未能避免漏诊,结论支持所有肺叶切除常规清扫或采样隆突下淋巴结。

要点

  • 隐匿性N2转移占11.0%,隆突下转移占3.5%。
  • 中下叶肿瘤隆突下N2发生率5.8%,显著高于上叶1.6%(p<0.01)。
  • 无论肿瘤位置及术前有创分期,均应常规清扫或采样隆突下淋巴结。

核心结论

  • 隆突下淋巴结转移在所有肺叶的非小细胞肺癌中均常见,应常规清扫或采样以避免分期不足。

研究设计与样本

  • 基于全国肺癌登记数据的回顾性队列研究,纳入2004至2014年5577例连续接受手术的非小细胞肺癌患者,排除临床N2病例。

主要发现

  • 最终病理发现隐匿性N2疾病612例(11.0%),其中隆突下转移193例(3.5%)。
  • 中下叶肿瘤的隆突下N2发生率5.8%,显著高于上叶的1.6%(p<0.01)。
  • 术前有创纵隔分期在73.4%(4097/5577)患者中实施,在最终N2组为87.3%(534/612,p<0.01),在隆突下N2组为89.6%(173/193,p<0.01)。

关键数值与推荐

  • 推荐在所有非小细胞肺癌肺叶切除术中常规清扫或采样隆突下淋巴结,无论肿瘤位置及术前有创分期结果。

临床怎么用

  • 心胸外科医生在肺叶切除时应常规清扫或采样隆突下淋巴结,避免因遗漏导致分期不足。

局限性

  • 研究为回顾性登记分析,未报告手术并发症及长期生存数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mediastinal staging is of paramount importance for planning of treatment in non-small cell lung cancer (NSCLC). Single institution reports recently claimed that subcarinal lymph node dissection during resection of upper lobe NSCLC could be spared. We used a complete national lung cancer registry to investigate patterns of unsuspected mediastinal lymph node involvement after lobectomy. METHODS: During an 11-year period (2004 to 2014) 5,577 consecutive patients who underwent operations for NSCLC were investigated for unsuspected mediastinal lymph node involvement (N2 disease) discovered at final histopathology. The analysis excluded patients with clinical N2 disease. We used a national registry to extract information for each patient about tumor location, histopathology, clinical and pathologic TNM stage, preoperative imaging modalities, and type of invasive mediastinal staging. RESULTS: Mediastinal lymph node dissection was performed in 5,577 patients during the operation, and unsuspected N2 disease was discovered in 612 (11.0%), and 193 (3.5%) had subcarinal metastasis. Subcarinal N2 disease was significantly more common in patients with lower-lobe or middle-lobe cancers compared with upper-lobe cancers (5.8% vs 1.6%, p < 0.01). Preoperative invasive mediastinal staging was performed in 73.4% (4,097 of 5,577) of all patients and significantly more frequently in patients who eventually had N2 disease (87.3% [534 of 612], p < 0.01) as well subcarinal N2 disease (89.6% [173 of 193], p < 0.01). CONCLUSIONS: Subcarinal lymph node metastases were common despite frequent use of preoperative invasive mediastinal staging in lower-lobe, middle-lobe, and upper-lobe NSCLC. Subcarinal lymph nodes should be dissected or sampled routinely during operations for NSCLC to avoid understaging-regardless of preoperative invasive mediastinal staging and tumor location.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Eckardt J, Jakobsen E, Licht PB, et al. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location. Ann Thorac Surg. 2017. PMID: 28109572. doi:10.1016/j.athoracsur.2016.09.109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。